Destiny Pharma plc
An innovative pharmaceutical company dedicated to the development of novel antimicrobial products.
Launch date
Employees
Market cap
AUD7.8m
Enterprise valuation
(AUD5m) (Public information from Aug 2024)
Share price
£0.02994 DEST.L
Company register number 03167025
Lewes England (HQ)
Financials
Estimates*
| GBP | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | - | - | - | - | 1.5m |
| EBITDA | (6.1m) | (5.6m) | (6.5m) | (6.3m) | (7.8m) | (6.7m) | - |
| Profit | - | (4.7m) | (5.4m) | (5.3m) | (6.5m) | (5.7m) | - |
| EV / EBITDA | -1.1x | -1.1x | -0.5x | -1.4x | -0.4x | -0.7x | - |
| R&D budget | - | 2.9m | - | - | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
£4.8m | Early VC | ||
£2.8m | Early VC | ||
| N/A | €16.7m Valuation: €71.3m -41.0x EV/LTM EBITDA | IPO | |
* | N/A | £1.6m | Grant |
| N/A | £11.5m | Post IPO Equity | |
* | N/A | Grant | |
* | N/A | £7.3m | Post IPO Equity |
| Total Funding | AUD18.8m | ||
Related Content
Recent News about Destiny Pharma plc
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.